BSE Live
Dec 10, 16:01Prev. Close
190.10
Open Price
189.95
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 10, 15:52Prev. Close
190.11
Open Price
189.61
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
191.21 (20587)
| Cash Flow of Marksans Pharma (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | 0.63 | 2.39 | 19.27 | 9.56 | 31.32 | |
| Net CashFlow From Operating Activities | 11.61 | 89.27 | -25.49 | -28.40 | 13.61 | |
| Net Cash Used In Investing Activities | -33.89 | -141.56 | -69.44 | -14.11 | -28.19 | |
| Net Cash Used From Financing Activities | 41.78 | 22.10 | -20.33 | 3.36 | 202.37 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 19.50 | -30.19 | -115.25 | -39.16 | 187.79 | |
| Cash And Cash Equivalents Begin of Year | 13.01 | 43.20 | 158.45 | 197.61 | 9.51 | |
| Cash And Cash Equivalents End Of Year | 32.51 | 13.01 | 43.20 | 158.45 | 197.30 |
26.11.2025
Marksans Pharma Consolidated September 2025 Net Sales at Rs 720.41 crore, up 12.23% Y-o-Y
24.11.2025
Marksans Pharma Standalone September 2025 Net Sales at Rs 320.44 crore, up 3.83% Y-o-Y
09.09.2025
Marksans Pharma Standalone June 2025 Net Sales at Rs 319.73 crore, up 25.62% Y-o-Y
20.05.2025
Marksans Pharma Consolidated March 2025 Net Sales at Rs 708.46 crore, up 26.51% Y-o-Y